Interleukin-17 produced by Th17 cells activates synovial fibroblasts, endothelial cells, and infiltrated immune cells in the synovium, leading to promotion of osteoclastogenesis and synovial inflammation during RA pathogenesis [22,24]. The gene discussed is IL17A; the disease is rheumatoid arthritis.